<DOC>
	<DOCNO>NCT01209806</DOCNO>
	<brief_summary>The purpose study determine whether administration PEG along simethicone reduce incidence colonic bubble interfere polyp detection .</brief_summary>
	<brief_title>The Effects Moviprep With Simethicone Colonic Bubbles</brief_title>
	<detailed_description>evaluate simethicone well placebo decrease gas colon time colonoscopy easy endoscopist see polyp</detailed_description>
	<mesh_term>Aluminum hydroxide , magnesium hydroxide , drug combination</mesh_term>
	<mesh_term>Aluminum hydroxide , magnesium hydroxide , simethicone drug combination</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<mesh_term>TEMPO</mesh_term>
	<criteria>Elective outpatient undergo colonoscopy use split dose PEGELS sodium ascorbate ascorbic acid Unable unwilling give inform consent Age &lt; 18 year Pregnant Breast feeding Established suspect gastroparesis Pseudoobstruction establish suspect Severe constipation ( &lt; 1 BM week ) Bowel obstruction Greater 50 % resection colon Chronic nausea vomit Consumed &gt; 100 % standard dose PEGELS ( i.e . 2L ) G6PD deficiency PEG allergy Significant psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>